Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
Surface Oncology Presents Clinical Data On SRF617 At European Society For Medical Oncology Immuno-Oncology Congress (ESMO-IO) 2021
Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that new data from the ongoing Phase
Surface Oncology Says Preclinical Data Supporting Therapeutic Potential Of Co’s Lead Clinical Programs, SRF617 And SRF388, Presented At Society For Immunotherapy Of Cancer 2021 Annual Meeting
Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that two scientific posters sharing
Surface Oncology To Present Preclinical Data For Lead Clinical Programs At Society For Immunotherapy Of Cancer 2021 Annual Meeting
Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that scientific posters sharing
Cathie Wood’s ARK Invest Posts Fund Purchases For Tuesday, Oct. 5, 2021: TDOC, PACB, BEAM, SGFY, TWOU, DNA, SSYS, MKFG, ACHR, BLDE, VLD, NIU, SQ, VUZI, ADPT, SURF, QSI, SLGC, MASS, DYNS, PATH, HOOD, TOST, PRNT
Teladoc Health (TDOC) - 154,175 Shares
Pacific Biosciences Of California (PACB) - 783,580
Beam Therapeutics (BEAM) - 104,491
Signify Health (SGFY) - 749,117
2U (TWOU) - 166,427
Gingko Bioworks (DNA) -
Cathie Wood’s ARK Invest Posts Fund Purchases For Thursday, Sept. 30, 2021: BEAM, DNA, AVAV, ACHR, PD, TWOU, VCYT, QSI, SURF, MASS, PACB, DYNS, BLDE
Beam Therapeutics (BEAM) - 130,645 Shares
Gingko Bioworks (DNA) - 173,518
AeroVironment (AVAV) - 16,200
Archer Aviation (ACHR) - 95,564
PagerDuty (PD)
2U (TWOU) - 12,749
Veracyte (VCYT) - 6,478
Quantum-Si (QSI)
35 Stocks Moving In Monday’s Mid-Day Session
Gainers
ZIVO Bioscience, Inc. (NASDAQ: ZIVO) jumped 145% to $6.86 after declining around 17% on Friday.